Nov 25, 2019: 15 Companies received warning letter by U.S. Food and Drug Administration the for illegally selling products containing cannabidiol that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).
The FDA published a revised Consumer Update detailing safety concerns about CBD products.The FDA continues to explore potential pathways for various types of CBD products to be lawfully marketed related to the safety of CBD products.
Some of the available data raise serious concerns about potential harm from CBD including potential liver injury, interactions with other drugs, drowsiness, diarrhea, changes in mood, and decrease testosterone levels and impair sexual behavior in males.
CBD preparations are  oil drops, capsules, syrups, food products such as chocolate bars and teas, and topical lotions and creams. https://fda.einnews.com/pr_news/503206803/fda-warns-15-companies-for-illegally-selling-various-products-containing cannabidiol-as-agency-details-safety-concerns
